Nausea can be intense during the first few days after your initial 7.5 mg injection
Hypoglycemia Symptoms: If you're taking these medications alongside insulin or sulfonylureas, contact your provider if you experience repeated episodes of low blood glucose (below 70 mg/dL) or symptoms such as shakiness, sweating, confusion, or rapid heartbeat
When evaluating Southaven providers, consider their medical credentials, how they handle side effects and dosage adjustments, and whether they offer ongoing support
In clinical studies , people lost approximately 2% of their baseline body weight by the end of the first month
Conclusions Overall, the findings show that by 2022, semaglutide had become the predominant GLP-1RA among surveyed US users, likely reflecting its greater weight-management effectiveness reported in earlier research, as well as its 2021 approval for that indication